Women First Healthcare, Inc.


Nov 18, 02

05:20 ET Polycystic Ovary Syndrome Puts Spotlight on Female Facial Hair Growth

 
Sep 17, 02

10:01 ET Little-Known Beauty Secret, VANIQA(TM) Gains Favor Among American Women

 
Dec 21, 00

08:03 ET Women First Signs Agreement With Novation for Esclim(TM)

 
Dec 04, 00

08:07 ET The National Association of Nurse Practitioners in Women's Health Supports Women First's Daily Difference(TM)

 
Nov 27, 00

13:29 ET Women First HealthCare Chairman/CEO to Purchase Additional Shares of Common Stock in Market Transactions

 
Nov 16, 00

08:15 ET Women First HealthCare and Laboratoires Fournier, S.A. Revise Agreement to Strengthen Partnership for Esclim(TM)

 
Nov 13, 00

08:00 ET Women First HealthCare Announces Third Quarter Results

 
Nov 08, 00

16:59 ET Women First HealthCare to Report Third Quarter Results on November 13, 2000; Will Host Conference Call the Same Day

 
08:15 ET Women First HealthCare Receives $5.5 Million Payment Under Recently Revised Ortho-McNeil Pharmaceutical Agreements

 
Oct 17, 00

18:52 ET Women First HealthCare, Inc. Revises Its Agreements With Ortho-McNeil Pharmaceutical, Inc.

 
Sep 11, 00

10:02 ET Women First HealthCare Appoints New CFO

 
Sep 05, 00

14:32 ET New CIO Named at Women First HealthCare

 
Aug 18, 00

09:30 ET Women First Commences Internet Partnership With Major U.S. Health Care Professional Organization

 
Aug 14, 00

16:52 ET Women First HealthCare Announces Second Quarter Results

 
Aug 08, 00

16:40 ET Pharmaceutical Division Leader Appointed at Women First HealthCare

 
Aug 04, 00

18:50 ET Women First's 'Woman First'

 
Aug 03, 00

18:55 ET Women First HealthCare Welcomes Mary Lake Polan, MD, PhD To Health Advisory Board

 
Jun 27, 00

17:06 ET Women First HealthCare Announces Major Organizational Changes

 
Jun 16, 00

06:00 ET Tufts University and Women First HealthCare Introduce First-Of-Its-Kind Dietary Supplement Line For Women Over 45

 
May 12, 00

06:15 ET Women First HealthCare Announces First Quarter Results

 
Mar 08, 00

06:15 ET Women First HealthCare Announces 1999 Year End and Fourth Quarter Results

 
Feb 17, 00

06:01 ET Women First HealthCare Signs Strategic Agreement With CareGuide.com - Womenfirst.com to Offer Co-Branded Online Child and Elder Care Resource -

 
Jan 18, 00

08:15 ET Women First HealthCare, Inc. Begins Co-Promoting ORTHO-PREFEST(TM) With Ortho-McNeil, Inc.

 
Dec 16, 99

08:32 ET Prestigious National Coro Fellowship Now Accepting Applications

 
08:31 ET Women First HealthCare's New Survey Finds Women At High Risk for Cardiovascular Disease

 
Nov 12, 99

08:15 ET Women First HealthCare Announces Third Quarter Results

 
08:02 ET Women First HealthCare To Sell ESCLIM Estradiol Transdermal System in U.S.

 
Nov 05, 99

08:30 ET Online Risk Assessment for Heart Disease Now Available at www.womenfirst.com

 
Oct 25, 99

12:02 ET Women First HealthCare Pleased with FDA Approval of ORTHO-PREFEST (17 beta-estradiol/norgestimate)

 
Aug 26, 99

09:00 ET Program Introduced to Create Awareness of Cardiovascular Disease Risk in Women

 
Aug 05, 99

20:38 ET Women First HealthCare Posts Second Quarter 1999 Financial Results

 
Jul 22, 99

19:32 ET Women First HealthCare, Inc. and Groupe Fournier Sign Agreement to Market Esclim, a Transdermal Estrogen Patch, in the U.S.

 
Jul 21, 99

19:25 ET Women First HealthCare, Inc. Announces Exercise of Over-Allotment Option

 
Jul 01, 99

19:24 ET Women First HealthCare, Inc. Announces Completion Of 4,500,000 Share Initial Public Offering

 
Jun 29, 99

19:22 ET Women First HealthCare, Inc. Commences Initial Public Offering of Common Stock

 
Jun 02, 99

19:19 ET Deepak Chopra, MD and Women First HealthCare, Inc. Schedule Live Online Forums Dedicated to Women in Midlife

 
19:17 ET Women First HealthCare, Inc. Signs Co-Promotion Agreement with Ortho-McNeil Pharmaceutical, Inc.

 
May 11, 99

19:08 ET Women First HealthCare Launches www.womenfirst.com, a Comprehensive Health Resource for Midlife Women

 
Apr 19, 99

19:06 ET Women First HealthCare Commences Marketing of Pravachol (pravastatin sodium) Under a Co-Promotion Agreement with Bristol-Myers Squibb For U.S. OB/GYN Market

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.